Priligy 30 mg & 60 mg FC tablet
PDF Leaflet Revision Date: 15 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of premature ejaculation in men aged 18 to 64.
Dosage (summary)
Starting dose 30 mg, taken 1-3 hours before sexual activity; max 60 mg if needed.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not indicated for women; limited data show no adverse effects on pregnancy.
Key Drug Interactions
- CYP2D6 inhibitors
- CYP3A4 inhibitors
- SSRIs
- MAOIs
Contraindications
- Hypersensitivity to dapoxetine
- Severe hepatic impairment
- Uncontrolled epilepsy
Common side effects
- Nausea
- Dizziness
- Headache
- Diarrhea
- Insomnia
Counselling Points
- Take only when sexual activity is anticipated
- Avoid alcohol
- Be cautious of dizziness or light-headedness
Serious warnings
- Orthostatic hypotension
- Risk of syncope
- Caution in cardiovascular disease
Important Disclaimer
The Priligy 30 mg & 60 mg FC tablet professional information leaflet below is the property of Lebasi Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
